These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871 [TBL] [Abstract][Full Text] [Related]
25. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664 [TBL] [Abstract][Full Text] [Related]
26. Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion. Chakravorty SJ; Cockwell P; Girdlestone J; Brooks CJ; Savage CO Clin Exp Immunol; 2002 Jul; 129(1):150-9. PubMed ID: 12100035 [TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Ahn SY; Cho CH; Park KG; Lee HJ; Lee S; Park SK; Lee IK; Koh GY Am J Pathol; 2004 May; 164(5):1663-72. PubMed ID: 15111313 [TBL] [Abstract][Full Text] [Related]
28. The ascochlorin derivative, AS-6, inhibits TNF-alpha-induced adhesion molecule and chemokine expression in rat vascular smooth muscle cells. Park KG; Lee KM; Chang YC; Magae J; Ando K; Kim KB; Kim YN; Kim HS; Park JY; Lee KU; Lee IK Life Sci; 2006 Dec; 80(2):120-6. PubMed ID: 16989870 [TBL] [Abstract][Full Text] [Related]
29. Heparin inhibits IFN-gamma-induced fractalkine/CX3CL1 expression in human endothelial cells. Hatakeyama M; Imaizumi T; Tamo W; Yamashita K; Yoshida H; Fukuda I; Satoh K Inflammation; 2004 Feb; 28(1):7-13. PubMed ID: 15072225 [TBL] [Abstract][Full Text] [Related]
30. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis. Fang IM; Lin CP; Yang CM; Chen MS; Yang CH Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495 [TBL] [Abstract][Full Text] [Related]
31. Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. Hurst LA; Bunning RA; Couraud PO; Romero IA; Weksler BB; Sharrack B; Woodroofe MN J Neuroimmunol; 2009 May; 210(1-2):108-12. PubMed ID: 19324423 [TBL] [Abstract][Full Text] [Related]
32. TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling. Hsiao HY; Mak OT; Yang CS; Liu YP; Fang KM; Tzeng SF Glia; 2007 Jan; 55(2):214-23. PubMed ID: 17091492 [TBL] [Abstract][Full Text] [Related]
33. Membrane-bound form of fractalkine induces IFN-gamma production by NK cells. Yoneda O; Imai T; Nishimura M; Miyaji M; Mimori T; Okazaki T; Domae N; Fujimoto H; Minami Y; Kono T; Bloom ET; Umehara H Eur J Immunol; 2003 Jan; 33(1):53-8. PubMed ID: 12594832 [TBL] [Abstract][Full Text] [Related]
34. Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia. Boddeke EW; Meigel I; Frentzel S; Biber K; Renn LQ; Gebicke-Härter P Eur J Pharmacol; 1999 Jun; 374(2):309-13. PubMed ID: 10422773 [TBL] [Abstract][Full Text] [Related]
35. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of cytokine-induced fractalkine production by bacterial invasion of human-dermal fibroblasts. Fahy OL; Coates NJ; McColl SR Lab Invest; 2003 May; 83(5):721-30. PubMed ID: 12746481 [TBL] [Abstract][Full Text] [Related]
37. 15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells. Imaizumi T; Matsumiya T; Tamo W; Shibata T; Fujimoto K; Kumagai M; Yoshida H; Cui XF; Tanji K; Hatakeyama M; Wakabayashi K; Satoh K Immunol Cell Biol; 2002 Dec; 80(6):531-6. PubMed ID: 12406386 [TBL] [Abstract][Full Text] [Related]
38. Characterization of synergistic induction of CX3CL1/fractalkine by TNF-alpha and IFN-gamma in vascular endothelial cells: an essential role for TNF-alpha in post-transcriptional regulation of CX3CL1. Matsumiya T; Ota K; Imaizumi T; Yoshida H; Kimura H; Satoh K J Immunol; 2010 Apr; 184(8):4205-14. PubMed ID: 20231691 [TBL] [Abstract][Full Text] [Related]
39. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. Maciejewski-Lenoir D; Chen S; Feng L; Maki R; Bacon KB J Immunol; 1999 Aug; 163(3):1628-35. PubMed ID: 10415068 [TBL] [Abstract][Full Text] [Related]
40. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats. Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]